Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer

1. Massard, C.
2. Chi, K.N.
3. Castellano, D.
4. de Bono, J.
5. Gravis, G.
6. Dirix, L.
7. Machiels, J.-P.
8. Mita, A.
9. Gonzalez, B.M.
10. Turri, S.
11. Maier, J.
12. Csonka, D.
13. Chakravartty, A.
14. Fizazi, K.